Evaluation of SORD mutations as a novel cause of Charcot-Marie-Tooth disease

20Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Biallelic mutations in the sorbitol dehydrogenase (SORD) encoding gene were recently identified as a common genetic cause in autosomal-recessive CMT patients. Here, we investigated the clinical, genetic, and electrophysiological characteristics of three CMT patients with biallelic SORD mutations from a Chinese cohort. Two patients harbored c.757delG (p.A253Qfs*27) homozygous mutations, and one patient carried both c.757delG (p.A253Qfs*27) and c.625C>T (p.R209X) compound heterozygous mutations. Interestingly, the two patients homozygous for the c.757delG mutation exhibited positive responses for pinprick test. In conclusion, we confirmed SORD mutations as causative for CMT and further expanded the mutational and phenotypic spectrum of SORD-related CMT.

Cite

CITATION STYLE

APA

Yuan, R. Y., Ye, Z. L., Zhang, X. R., Xu, L. Q., & He, J. (2021). Evaluation of SORD mutations as a novel cause of Charcot-Marie-Tooth disease. Annals of Clinical and Translational Neurology, 8(1), 266–270. https://doi.org/10.1002/acn3.51268

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free